Risk-benefit assessment of seaweed Allergenicity risk assessment of novel protein

被引:4
|
作者
Garciarena, Irene Nuin [1 ]
Poulsen, Morten [1 ]
Bogh, Katrine Lindholm [1 ]
机构
[1] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark
关键词
risk-benefit; allergenicity risk assessment; seaweed; novel food; novel protein; FOOD ALLERGENS; DIGESTION; STABILITY;
D O I
10.2903/j.efsa.2022.e200414
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
As the world population rapidly grows, there is a clear need for alternative food sources, particularly for the provision of protein. Seaweed is one such alternative source of protein that requires greater investigation. In this context, a working programme within the European Food Risk Assessment (EU-FORA) Fellowship Programme framework was developed at National Food Institute - Technical University of Denmark. This Programme is an initiative of the EFSA with the aim to build a European risk assessment community. The purpose of this technical report is to describe the activities in which the fellow was involved. As part of the Research Group for Risk-Benefit, the fellow performed a risk-benefit assessment of seaweed Palmaria palmata gaining an in-depth expertise in all the steps. The health impact of Palmaria palmata consumption was estimated, considering its high nutritional value but also highlighting concerns towards some components. Simultaneous to the work on the risk-benefit, the fellow also worked within the Research Group for Food Allergy, specifically on the allergenicity risk assessment of a plant-based novel protein (seaweed protein) using different laboratory assays. Seaweed protein digestibility was assessed, and its digestion products were characterised and assessed for immunogenicity. Finally, the fellow collaborated with the Research Group for Microbial Biotechnology and Biorefining in the development of a novel food (alfalfa protein) application dossier to be submitted to EFSA, gaining expertise in the risk assessment of a novel food. In conclusion, the present working programme, together with additional activities and training provided by different institutions, enabled the fellow to gain a broader perspective in food safety, particularly concerning seaweed, novel foods and the safety assessment of novel proteins.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Risk-Benefit Assessment of Foods
    Assuncao, R.
    Pires, S. M.
    Nauta, M.
    EFSA JOURNAL, 2019, 17
  • [2] Novel foods and allergy Regulations and risk-benefit assessment
    van Putten, M. C.
    Kleter, G. A.
    Gilissen, L. J. W. J.
    Gremmen, B.
    Wichers, H. J.
    Frewer, L. J.
    FOOD CONTROL, 2011, 22 (02) : 143 - 157
  • [3] A Risk-Benefit Assessment of Antileukotrienes in Asthma
    Lewis J. Smith
    Drug Safety, 1998, 19 : 205 - 218
  • [4] A Risk-Benefit Assessment of Amifostine in Cytoprotection
    May Mabro
    Sandrine Faivre
    Eric Raymond
    Drug Safety, 1999, 21 : 367 - 387
  • [5] A RISK-BENEFIT ASSESSMENT OF RISPERIDONE IN SCHIZOPHRENIA
    CURTIS, VA
    KERWIN, RW
    DRUG SAFETY, 1995, 12 (02) : 139 - 145
  • [6] THE RISK-BENEFIT ASSESSMENT OF ANTIDEPRESSANT DRUGS
    HENRY, JA
    MARTIN, AJ
    MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1987, 2 (06): : 445 - 462
  • [7] A RISK-BENEFIT ASSESSMENT OF TACROLIMUS IN TRANSPLANTATION
    WINKLER, M
    CHRISTIANS, U
    DRUG SAFETY, 1995, 12 (05) : 348 - 357
  • [8] A risk-benefit assessment of abciximab in angioplasty
    Kleiman, NS
    DRUG SAFETY, 1999, 20 (01) : 43 - 57
  • [9] A RISK-BENEFIT ASSESSMENT OF TAMOXIFEN THERAPY
    CATHERINO, WH
    JORDAN, VC
    DRUG SAFETY, 1993, 8 (05) : 381 - 397
  • [10] Clinical equipoise and risk-benefit assessment
    Miller, Franklin G.
    CLINICAL TRIALS, 2012, 9 (05) : 621 - 627